HOLUBIAK MYRON Z

Director at Option Care Health, Inc. · on record since May 25, 2006
Director at Adhera Therapeutics, Inc. · on record since Jun 15, 2006
Director at CITIUS ONCOLOGY, INC. · on record since Aug 30, 2024
Secretary at CITIUS ONCOLOGY, INC. · on record since Dec 16, 2024
Director at ASSEMBLY BIOSCIENCES, INC. · on record since Dec 23, 2010
Director at CHRONIMED INC · on record since Nov 21, 2003
Director at Intellicell Biosciences, Inc. · on record since Jan 14, 2013
Director at Citius Pharmaceuticals, Inc. · on record since Oct 27, 2015
10% owner at Citius Pharmaceuticals, Inc. · on record since Aug 15, 2018
Vice Chairman at Citius Pharmaceuticals, Inc. · on record since Apr 8, 2016

Insider trading activity of HOLUBIAK MYRON Z

Transactions on record: 121; since Nov 21, 2003

Open-market buys: 4; $1.7M

Open-market sells: 24; $1.1M

Companies traded: 6; last filing Dec 22, 2025

Figures computed from official regulatory filings — .

Companies where HOLUBIAK MYRON Z has traded

CITIUS ONCOLOGY, INC.8 tx · Dec 22, 2025
Citius Pharmaceuticals, Inc.31 tx · $1.7M · Aug 12, 2025
ASSEMBLY BIOSCIENCES, INC.14 tx · May 24, 2021
Option Care Health, Inc.56 tx · $1.7M · Jun 2, 2016
Adhera Therapeutics, Inc.11 tx · $661.1K · Aug 16, 2007
CHRONIMED INC1 tx · Nov 21, 2003

Track record of HOLUBIAK MYRON Z

Statistical track record

Free account

Open-market buys: 6

Last buy: Sep 27, 2019

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of HOLUBIAK MYRON Z

Co-insiders of HOLUBIAK MYRON Z

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
CITIUS ONCOLOGY, INC.Listing on record	Dec 22, 2025	Award	850,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CITIUS ONCOLOGY, INC.Listing on record	Dec 1, 2025	Award	850,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CITIUS ONCOLOGY, INC.Listing on record	Sep 23, 2025	Award	850,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CITIUS ONCOLOGY, INC.Listing on record	Sep 23, 2025	Award	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Aug 12, 2025	AwardD (derivative)	22,344	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Aug 12, 2025	OtherD (derivative)	-22,344	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Aug 12, 2025	OtherD (derivative)	-31,373	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Aug 12, 2025	AwardD (derivative)	31,373	—	n/a (No price was disclosed in the filing)	SEC
CITIUS ONCOLOGY, INC.Listing on record	Dec 16, 2024	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CITIUS ONCOLOGY, INC.Listing on record	Dec 16, 2024	AwardD (derivative)	300,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Nov 12, 2024	AwardD (derivative)	350,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Nov 12, 2024	AwardD (derivative)	75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Sep 27, 2024	AwardD (derivative)	558,597	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Sep 27, 2024	OtherD (derivative)	-784,314	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Sep 27, 2024	OtherD (derivative)	-558,597	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Sep 27, 2024	AwardD (derivative)	784,314	—	n/a (No price was disclosed in the filing)	SEC
CITIUS ONCOLOGY, INC.Listing on record	Aug 30, 2024	AwardD (derivative)	1,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CITIUS ONCOLOGY, INC.Listing on record	Aug 14, 2024	AwardD (derivative)	500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Apr 5, 2024	AwardD (derivative)	129,450	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Apr 5, 2024	OtherD (derivative)	-129,450	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Oct 12, 2023	AwardD (derivative)	400,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Oct 6, 2022	AwardD (derivative)	400,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Oct 13, 2021	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Oct 13, 2021	AwardD (derivative)	650,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Jul 26, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
CITIUS ONCOLOGY, INC.Listing on record	Dec 22, 2025	Award	850,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CITIUS ONCOLOGY, INC.Listing on record	Dec 1, 2025	Award	850,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CITIUS ONCOLOGY, INC.Listing on record	Sep 23, 2025	Award	850,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CITIUS ONCOLOGY, INC.Listing on record	Sep 23, 2025	Award	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Aug 12, 2025	AwardD (derivative)	22,344	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Aug 12, 2025	OtherD (derivative)	-22,344	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Aug 12, 2025	OtherD (derivative)	-31,373	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Aug 12, 2025	AwardD (derivative)	31,373	—	n/a (No price was disclosed in the filing)	SEC
CITIUS ONCOLOGY, INC.Listing on record	Dec 16, 2024	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CITIUS ONCOLOGY, INC.Listing on record	Dec 16, 2024	AwardD (derivative)	300,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Nov 12, 2024	AwardD (derivative)	350,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Nov 12, 2024	AwardD (derivative)	75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Sep 27, 2024	AwardD (derivative)	558,597	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Sep 27, 2024	OtherD (derivative)	-784,314	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Sep 27, 2024	OtherD (derivative)	-558,597	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Sep 27, 2024	AwardD (derivative)	784,314	—	n/a (No price was disclosed in the filing)	SEC
CITIUS ONCOLOGY, INC.Listing on record	Aug 30, 2024	AwardD (derivative)	1,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CITIUS ONCOLOGY, INC.Listing on record	Aug 14, 2024	AwardD (derivative)	500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Apr 5, 2024	AwardD (derivative)	129,450	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Apr 5, 2024	OtherD (derivative)	-129,450	—	n/a (No price was disclosed in the filing)	SEC
Citius Pharmaceuticals, Inc.Listing on record	Oct 12, 2023	AwardD (derivative)	400,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Oct 6, 2022	AwardD (derivative)	400,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Oct 13, 2021	AwardD (derivative)	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Oct 13, 2021	AwardD (derivative)	650,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Citius Pharmaceuticals, Inc.Listing on record	Jul 26, 2021	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC